Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226960 · ClinicalTrials.gov registry record · NA
Deprescribing in Outpatient Internal Medicine Practices
A NA study of Deprescribing, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07226960 is a NA study of Deprescribing that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07226960, a NA study of Deprescribing, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the impact of pharmacist-led medication reviews and deprescribing or de-escalation interventions on reducing the number of medications, falls, and hospitalizations, and improvement in quality of life in geriatric patients.
Conditions Studied
Interventions
- BEHAVIORAL medication review
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-11-12 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226960
The ClinicalTrials.gov registry entry for NCT07226960 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Deprescribing appearing as the primary indexed condition, and to 1 intervention - of which medication review is the first listed.
NCT07226960 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07226960 about?
NCT07226960 is a clinical study titled "Deprescribing in Outpatient Internal Medicine Practices". The purpose of this study is to evaluate the impact of pharmacist-led medication reviews and deprescribing or de-escalation interventions on reducing the number of medications, falls, and hospitalizations, and improvement in quality of life in geriatric patients.
What is the current status of trial NCT07226960?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-11-12. Estimated completion is 2026-04.
What conditions does trial NCT07226960 study?
This clinical trial studies the following conditions: Deprescribing.
What interventions are being tested in trial NCT07226960?
The interventions under investigation include: medication review (BEHAVIORAL).
Who is sponsoring clinical trial NCT07226960?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07226960 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.